Sethuraman Natarajan - Insider Transactions
Insider Type
individual
Companies
1
Average
65,411
Total Txns
17
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 17 | -17 | 0.00 | 1,111,982.78 | -1,111,982.78 |
| Total: | 0 | 17 | 10 | 0.00 | 1,111,982.78 | -1,111,982.78 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc. Common Stock US29384C1080 |
20.00 USD |
100 Sold |
2,000 USD |
29/11/2024 | 29/11/2024 |
| Entrada Therapeutics, Inc. Common Stock US29384C1080 |
20.26 USD |
4,088 Sold |
82,834 USD |
29/11/2024 | 02/12/2024 |
| Entrada Therapeutics, Inc. Common Stock US29384C1080 |
20.15 USD |
11,703 Sold |
235,786 USD |
29/11/2024 | 03/12/2024 |
| Entrada Therapeutics, Inc. Common Stock US29384C1080 |
20.04 USD |
2,700 Sold |
54,109 USD |
11/11/2024 | 13/11/2024 |
| Entrada Therapeutics, Inc. Common Stock US29384C1080 |
20.01 USD |
1,409 Sold |
28,191 USD |
11/11/2024 | 11/11/2024 |
| Entrada Therapeutics, Inc. Common Stock US29384C1080 |
18.18 USD |
5,171 Sold |
94,006 USD |
04/11/2024 | 05/11/2024 |
| Entrada Therapeutics, Inc. Common Stock US29384C1080 |
18.71 USD |
9,554 Sold |
178,752 USD |
04/11/2024 | 06/11/2024 |
| Entrada Therapeutics, Inc. Common Stock US29384C1080 |
18.02 USD |
749 Sold |
13,498 USD |
04/11/2024 | 04/11/2024 |
| Entrada Therapeutics, Inc. Common Stock US29384C1080 |
19.32 USD |
2,745 Sold |
53,024 USD |
04/11/2024 | 06/11/2024 |
| Entrada Therapeutics, Inc. Common Stock US29384C1080 |
18.00 USD |
600 Sold |
10,800 USD |
16/10/2024 | 16/10/2024 |